{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:02:17Z","timestamp":1790758937927,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000109","name":"Prostate Cancer Canada","doi-asserted-by":"publisher","award":["D2013-31"],"award-info":[{"award-number":["D2013-31"]}],"id":[{"id":"10.13039\/501100000109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004376","name":"Terry Fox Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ajpath.2019.04.006","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T09:01:26Z","timestamp":1560330086000},"page":"1451-1461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["CCN3\/Nephroblastoma Overexpressed Is a Functional Mediator of Prostate Cancer Bone Metastasis That Is Associated with Poor Patient Prognosis"],"prefix":"10.1016","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4869-5895","authenticated-orcid":false,"given":"Matthew","family":"Dankner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Ouellet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laudine","family":"Communal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dru","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew G.","family":"Annis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Barr\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Mes-Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2019.04.006_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrclinonc.2014.70","article-title":"Managing bone metastases and reducing skeletal related events in prostate cancer","volume":"11","author":"Gartrell","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ajpath.2019.04.006_bib2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrclinonc.2014.68","article-title":"High-risk prostate cancer: classification and therapy","volume":"11","author":"Chang","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ajpath.2019.04.006_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/mp.56.2.127","article-title":"Proposal for a unified CCN nomenclature","volume":"56","author":"Brigstock","year":"2003","journal-title":"Mol Pathol"},{"key":"10.1016\/j.ajpath.2019.04.006_bib4","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3892\/ijmm.2015.2390","article-title":"Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (review)","volume":"36","author":"Li","year":"2015","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ajpath.2019.04.006_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12079-012-0161-7","article-title":"CCN3 modulates bone turnover and is a novel regulator of skeletal metastasis","volume":"6","author":"Ouellet","year":"2012","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.ajpath.2019.04.006_bib6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1158\/0008-5472.CAN-16-1949","article-title":"Polycomb-mediated disruption of an androgen receptor feedback loop drives castration-resistant prostate cancer","volume":"77","author":"Fong","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2019.04.006_bib7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/onc.2012.602","article-title":"CCN3\/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor","volume":"33","author":"Wu","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2019.04.006_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/mp.54.4.275","article-title":"Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues","volume":"54","author":"Maillard","year":"2001","journal-title":"Mol Pathol"},{"key":"10.1016\/j.ajpath.2019.04.006_bib9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/carcin\/bgs108","article-title":"CCN3 increases cell motility and ICAM-1 expression in prostate cancer cells","volume":"33","author":"Chen","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ajpath.2019.04.006_bib10","doi-asserted-by":"crossref","first-page":"74506","DOI":"10.18632\/oncotarget.20171","article-title":"CCN3 promotes epithelial-mesenchymal transition in prostate cancer via FAK\/Akt\/HIF-1alpha-induced twist expression","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2019.04.006_bib11","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/carcin\/bgt103","article-title":"CCN3 promotes prostate cancer bone metastasis by modulating the tumor-bone microenvironment through RANKL-dependent pathway","volume":"34","author":"Chen","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ajpath.2019.04.006_bib12","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.18632\/oncotarget.1570","article-title":"Prostate cancer-derived CCN3 induces M2 macrophage infiltration and contributes to angiogenesis in prostate cancer microenvironment","volume":"5","author":"Chen","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2019.04.006_bib13","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/jcb.21262","article-title":"Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation","volume":"101","author":"Bleau","year":"2007","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ajpath.2019.04.006_bib14","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbrc.2008.02.010","article-title":"Inhibitory effect of CT domain of CCN3\/NOV on proliferation and differentiation of osteogenic mesenchymal stem cells, Kusa-A1","volume":"368","author":"Katsuki","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2019.04.006_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/mp.52.2.84","article-title":"Nuclear localisation of NOVH protein: a potential role for NOV in the regulation of gene expression","volume":"52","author":"Perbal","year":"1999","journal-title":"Mol Pathol"},{"key":"10.1016\/j.ajpath.2019.04.006_bib16","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.ajpath.2011.01.033","article-title":"CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone","volume":"178","author":"Ouellet","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2019.04.006_bib17","doi-asserted-by":"crossref","first-page":"e12093","DOI":"10.1371\/journal.pone.0012093","article-title":"ADAM10 releases a soluble form of the GPNMB\/Osteoactivin extracellular domain with angiogenic properties","volume":"5","author":"Rose","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2019.04.006_bib18","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1158\/1541-7786.MCR-07-0119","article-title":"Osteoactivin promotes breast cancer metastasis to bone","volume":"5","author":"Rose","year":"2007","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ajpath.2019.04.006_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12894-018-0392-x","article-title":"The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation","volume":"18","author":"Ouellet","year":"2018","journal-title":"BMC Urol"},{"key":"10.1016\/j.ajpath.2019.04.006_bib20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.tranon.2018.11.014","article-title":"Exosomal release of L-plastin by breast cancer cells facilitates metastatic bone osteolysis","volume":"12","author":"Tiedemann","year":"2018","journal-title":"Transl Oncol"},{"key":"10.1016\/j.ajpath.2019.04.006_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pros.10091","article-title":"Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells","volume":"52","author":"Corey","year":"2002","journal-title":"Prostate"},{"key":"10.1016\/j.ajpath.2019.04.006_bib22","article-title":"Xenograft models of human prostate cancer. Prostate Cancer","author":"Corey","year":"2007"},{"key":"10.1016\/j.ajpath.2019.04.006_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/pros.20300","article-title":"Spiculated periosteal response induced by intraosseous injection of 22Rv1 prostate cancer cells resembles subset of bone metastases in prostate cancer patients","volume":"65","author":"Henry","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.ajpath.2019.04.006_bib24","first-page":"2577","article-title":"Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer","volume":"54","author":"Thalmann","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2019.04.006_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/1097-0045(20000701)44:2<91::AID-PROS1>3.0.CO;2-L","article-title":"LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis","volume":"44","author":"Thalmann","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.ajpath.2019.04.006_bib26","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z","article-title":"Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID\/bg mice using LNCaP and lineage-derived metastatic sublines","volume":"77","author":"Wu","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2019.04.006_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jcb.20228","article-title":"Prostate specific antigen gene regulation by androgen receptor","volume":"93","author":"Kim","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ajpath.2019.04.006_bib28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Kang","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2019.04.006_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12079-009-0051-9","article-title":"Alternative splicing of CCN mRNAs \u2026 it has been upon us","volume":"3","author":"Perbal","year":"2009","journal-title":"J Cell Commun Signal"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294401831099X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294401831099X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:06:15Z","timestamp":1762081575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000294401831099X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S000294401831099X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2019.04.006","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CCN3\/Nephroblastoma Overexpressed Is a Functional Mediator of Prostate Cancer Bone Metastasis That Is Associated with Poor Patient Prognosis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2019.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}